Extrait

The purpose of the study is to investigate if rosuvastatin, added on top of all other medicines prescribed to subjects with symptomatic systolic heart failure, reduces the combined endpoint of cardiovascular death or non-fatal myocardial infarction or non-fatal stroke (time to first event)

Critère d'inclusion

• Heart failure

Pays

• Belgium
• Bulgaria
• Czech Republic
• Denmark
• Finland
• France
• Germany
• Hungary
• Ireland
• Netherlands
• Norway
• Poland
• Portugal
• Romania
• Russian Federation
• Slovakia
• South Africa
• Spain
• Sweden
• Switzerland
• United Kingdom

Liens

• ictrp
• nct